The influence of admission procedures on trust in vaccines
How to cite
Lergetporer, Philipp; Rittmannsberger, Thomas; Glätzle-Rützler, Daniela; Angerer, Silvia. 2021. "The influence of admission procedures on trust in vaccines." AEA RCT Registry. AEARCTR-0007388. https://doi.org/10.1257/rct.7388-1.0
Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.
* Primary investigator
Abstract
Recent surveys show that about 25 to 42 percent of Germans do not intend to vaccinate against Covid-19. However, ensuring high uptake rates is crucial for achieving herd immunity. One reason why vaccination readiness may be low is due to low trust in the vaccine. In a randomized vignette study, we investigate how the duration and type of the vaccine admission process affects trust in the vaccine, and intentions to get vaccinated.
Intervention
We investigate whether the duration and type of vaccine admission process affects trust in the vaccine, and intentions to get vaccinated. Therefore, we plan to run a vignette experiment in a nationally representative survey in Germany. We present respondents different hypothetical vignetts that describe a new anti-Covid vaccine. Across vignettes, we vary (i) the duration of the admission process, and (ii) the type of admission. After presenting the vignettes, we elicit respondents’ trust in the vaccine, intentions to get vaccinated.
Experimental design
We conduct the experiment in a sample of 2,000 adults aged between 18 and 69 years. The survey is conducted in cooperation with a survey institute. The recruitment and polling is managed by the survey institute, who collects the data via an online platform. That is, our participants answer the survey questions autonomously on their own digital devices. Randomization is carried out by the survey institute at the individual level, using a computer.
Our experiment is structured as follows:
Respondents of the survey will be randomly assigned (between subject) to
Treatment I (p=0.25), Treatment II (p=0.25), Treatment III (p=0.25), or Treatment IV (p=0.25).
Treatment I:
Stage 1: Presentation of vignette (version 1)
Stage 2: Questions: trust in the vaccine + intentions to get the vaccine.
Treatment II:
Stage 1: Presentation of vignette (version 2)
Stage 2: Questions: trust in the vaccine + intentions to get the vaccine.
Treatment III:
Stage 1: Presentation of vignette (version 3)
Stage 2: Questions: trust in the vaccine + intentions to get the vaccine.
Treatment IV:
Stage 1: Presentation of vignette (version 4)
Stage 2: Questions: trust in the vaccine + intentions to get the vaccine.
Design details
Cited by
No citation data available for this registration yet.